Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Jinrui Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the development, manufacturing, and commercialization of high-quality Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Established in 2004 and headquartered in Shenzhen's Pingshan District, the company has built a robust portfolio centered on anti-infectives, particularly cephalosporin antibiotics, as well as treatments for cardiovascular and gastrointestinal conditions. Jinrui Pharma operates state-of-the-art GMP-certified facilities that support both domestic supply and international export markets. In addition to its product sales, the company provides contract development and manufacturing organization (CDMO) services, leveraging its expertise in chemical synthesis and formulation. Its commitment to international quality standards has enabled it to establish a significant presence in the global generic drug supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinrui Pharma.